Details for 2019175120

Up to date per 01.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE FORMULIERUNGEN ENTHALTEND 4-{(1 R)-2-[(6-{2-[(2,6-DICHLOROBENZYL)OXY]ETHOXY}HEXYL)AMINO]-1-HYDROXYETHYL}-2-(HYDROXYMETHYL)PHENOL

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019175120

EP Publication Number

3578169

E-Number

1697119

Language

PCT Number

Publication Date

11.12.2019 A

26.06.2024 B1

Registration Date

26.06.2024

AT Publication Date

15.07.2024

Application Date

26.02.2009

Registration Number

Priorities

IPC

A61K 9/00 20060101AFI20240328BHEP

Maximum Duration of Protection

26.02.2029

Owner

Glaxo Group LimitedGSK Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NYGB

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

BAKER, DarrellGlaxoSmithKline Stockley Park West Uxbridge, Middlesex UB11 1BTGB

BRUCE, MarkGlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NYGB

THOMAS, MarianGlaxoSmithKline Park Road Ware, Hertfordshire SG12 ODPGB

Information about Fees